| Name | Cvs Pharmacy # 04223 |
|---|---|
| Organization Name | Ohio Cvs Stores Llc |
| Location | 3100 Cleveland Ave, Columbus, Ohio 43224 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (614) 263-0923 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Pancreatic cancer death rates in the European Union have increased by 5% between 1990 and 2016, a report launched today reveals. This is the highest increase in any of the EU's top five cancer killers which, as well as pancreatic cancer, includes lung, colorectal, breast and prostate cancer.
A new Mayo Clinic study suggests that removing the entire kidney from younger patients with small kidney tumors may lead to decreased overall survival compared with an operation that removes the tumor but leaves the kidney intact.
Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.
In a first of its kind study, researchers have found that using two way audio-video telemedicine to deliver stroke care, also known as telestroke, appears to be cost-effective for rural hospitals that don't have an around-the-clock neurologist, or stroke expert, on staff.
› Verified 6 days ago
| NPI Number | 1730282567 |
| Organization Name | OHIO CVS STORES LLC |
| Doing Business As | CVS PHARMACY 04223 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3100 Cleveland Ave, Columbus, OH 43224 |
| Phone Number | 614-261-4475 |
News Archive
Pancreatic cancer death rates in the European Union have increased by 5% between 1990 and 2016, a report launched today reveals. This is the highest increase in any of the EU's top five cancer killers which, as well as pancreatic cancer, includes lung, colorectal, breast and prostate cancer.
A new Mayo Clinic study suggests that removing the entire kidney from younger patients with small kidney tumors may lead to decreased overall survival compared with an operation that removes the tumor but leaves the kidney intact.
Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.
In a first of its kind study, researchers have found that using two way audio-video telemedicine to deliver stroke care, also known as telestroke, appears to be cost-effective for rural hospitals that don't have an around-the-clock neurologist, or stroke expert, on staff.
› Verified 6 days ago
News Archive
Pancreatic cancer death rates in the European Union have increased by 5% between 1990 and 2016, a report launched today reveals. This is the highest increase in any of the EU's top five cancer killers which, as well as pancreatic cancer, includes lung, colorectal, breast and prostate cancer.
A new Mayo Clinic study suggests that removing the entire kidney from younger patients with small kidney tumors may lead to decreased overall survival compared with an operation that removes the tumor but leaves the kidney intact.
Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.
In a first of its kind study, researchers have found that using two way audio-video telemedicine to deliver stroke care, also known as telestroke, appears to be cost-effective for rural hospitals that don't have an around-the-clock neurologist, or stroke expert, on staff.
› Verified 6 days ago
Cresthaven Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2577 S Hamilton Rd, Columbus, Ohio 43232 Phone: (614) 600-1544 | |
Steel City Medical Supplies Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5900 Roche Dr, Columbus, Ohio 43229 Phone: (614) 406-1980 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2124 Citygate Dr, Columbus, Ohio 43219 Phone: (614) 351-5920 | |
Tamarkin Company Type: Community/Retail Pharmacy Location: 840 W 3rd Ave, Columbus, Ohio 43212 Phone: (614) 294-2344 | |
Giant Eagle Pharmacy #6513 Type: Pharmacy Location: 6867 East Broad Street, Columbus, Ohio 43213 Phone: (614) 866-3079 |